Luye Pharma Group Ltd (LUP) — Cash Flow Quality Index
Luye Pharma Group Ltd (LUP) has a Cash Flow Quality Index of 4.60x as of June 2023. Operating cash flow of €344.86 Million exceeds net income of €74.99 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Luye Pharma Group Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Luye Pharma Group Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Luye Pharma Group Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see LUP operating cash flow.
Annual Cash Flow Quality Index for Luye Pharma Group Ltd (2016–2025)
Year-by-year earnings quality comparison for Luye Pharma Group Ltd.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.88x | €1.78 Billion | €618.75 Million | ▲ +710.6% |
| 2024 | 0.36x | €167.76 Million | €471.89 Million | ▼ -88.1% |
| 2023 | 3.00x | €1.60 Billion | €532.61 Million | ▲ +9.6% |
| 2022 | 2.73x | €1.65 Billion | €604.81 Million | ▲ +87.0% |
| 2020 | 1.46x | €1.03 Billion | €706.59 Million | ▲ +51.0% |
| 2019 | 0.97x | €1.42 Billion | €1.47 Billion | ▲ +20.8% |
| 2018 | 0.80x | €1.05 Billion | €1.30 Billion | ▼ -18.3% |
| 2017 | 0.98x | €964.10 Million | €981.37 Million | ▲ +47.9% |
| 2016 | 0.66x | €592.03 Million | €891.54 Million | — |